Supreme Court Rejects Most Pharma Cases This Term, But Patent Settlements Stir Interest
This article was originally published in The Pink Sheet Daily
Executive Summary
High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.